ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626760 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626760; 2) Community: the network communities that were significantly associated with the response to NSC 626760; 3) Molecule: the relationships between components within communities and NSC 626760; 4) MDR: the compounds that were significantly associated with the NSC 626760.

NSC Compound Enrichment Correlation
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0385613993886001 -0.12611465
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0385613993886001 0.41335508
NSC 33570 Null 0.0385613993886001 0.095649019
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.070111276
NSC 349622 Cytovaricin 0.0385613993886001 0.2748306
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0385613993886001 0.057993868
NSC 371777 Null 0.0385613993886001 0.031936322
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0385613993886001 -0.05666364
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0385613993886001 0.11489677
NSC 603071 Aminocamptothecin 0.0385613993886001 0.050566938
Total:112  Current:80    [First] [Prev] [Next] [Last]